These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 27760684)
1. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa. Hosek S; Celum C; Wilson CM; Kapogiannis B; Delany-Moretlwe S; Bekker LG J Int AIDS Soc; 2016; 19(7(Suppl 6)):21107. PubMed ID: 27760684 [TBL] [Abstract][Full Text] [Related]
2. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350 [TBL] [Abstract][Full Text] [Related]
3. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study. Cholo FA; Dada S; Martin CE; Mullick S J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102 [TBL] [Abstract][Full Text] [Related]
4. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa. Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000 [TBL] [Abstract][Full Text] [Related]
5. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries. Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512 [TBL] [Abstract][Full Text] [Related]
6. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting. Giovenco D; Kuo C; Underhill K; Hoare J; Operario D Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792 [TBL] [Abstract][Full Text] [Related]
7. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa. Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053 [TBL] [Abstract][Full Text] [Related]
8. PrEP implementation research in Africa: what is new? Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680 [TBL] [Abstract][Full Text] [Related]
9. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol. Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754 [TBL] [Abstract][Full Text] [Related]
10. Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States. Taggart T; Bond KT; Ritchwood TD; Smith JC J Int AIDS Soc; 2019 Jul; 22(7):e25363. PubMed ID: 31369211 [TBL] [Abstract][Full Text] [Related]
11. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa. Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487 [TBL] [Abstract][Full Text] [Related]
12. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial. Gill K; Johnson L; Dietrich J; Myer L; Marcus R; Wallace M; Pidwell T; Mendel E; Fynn L; Jones K; Wiesner L; Slack C; Strode A; Spiegel H; Hosek S; Rooney J; Gray G; Bekker LG Lancet Child Adolesc Health; 2020 Dec; 4(12):875-883. PubMed ID: 33222803 [TBL] [Abstract][Full Text] [Related]
13. Implementing Differentiated and Integrated HIV Prevention Services for Adolescent Girls and Young Women: Experiences From Oral PrEP Rollout in Primary Care Services in South Africa. Butler V; Kutywayo A; Martin CE; Pleaner M; Mojapele MV; Ncube S; Fipaza Z; Mundeta B; Mullick S J Adolesc Health; 2023 Dec; 73(6S):S58-S66. PubMed ID: 37953010 [TBL] [Abstract][Full Text] [Related]
14. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study. Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669 [TBL] [Abstract][Full Text] [Related]
15. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505 [TBL] [Abstract][Full Text] [Related]
16. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S; J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874 [TBL] [Abstract][Full Text] [Related]
17. Implementation Strategies to Increase PrEP Uptake in the South. Sullivan PS; Mena L; Elopre L; Siegler AJ Curr HIV/AIDS Rep; 2019 Aug; 16(4):259-269. PubMed ID: 31177363 [TBL] [Abstract][Full Text] [Related]
18. Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa. Busang J; Zuma T; Herbst C; Okesola N; Chimbindi N; Dreyer J; Mtshali N; Smit T; Ngubane S; Hlongwane S; Gumede D; Jalazi A; Mdluli S; Bird K; Msane S; Danisa P; Hanekom W; Lebina L; Behuhuma N; Hendrickson C; Miot J; Seeley J; Harling G; Jarolimova J; Sherr L; Copas A; Baisley K; Shahmanesh M BMC Public Health; 2023 Aug; 23(1):1553. PubMed ID: 37582746 [TBL] [Abstract][Full Text] [Related]
19. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis. Roberts ST; Mancuso N; Williams K; Nabunya HK; Mposula H; Mugocha C; Mvinjelwa P; Garcia M; Szydlo DW; Soto-Torres L; Ngure K; Hosek S J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551 [TBL] [Abstract][Full Text] [Related]
20. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa. Jamieson L; Gomez GB; Rebe K; Brown B; Subedar H; Jenkins S; Shoko N; Bekker LG; Johnson LF; Meyer-Rath G AIDS; 2020 May; 34(6):883-891. PubMed ID: 32004205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]